Kataoka Daisuke, Fujiwara Hiromitsu, Kawakami Tomoko, Tanaka Yuko, Tanimoto Ayako, Ikawa Shiro, Tanaka Yoshinori
Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
Int J Antimicrob Agents. 2003 Dec;22(6):601-6. doi: 10.1016/s0924-8579(03)00244-9.
Stenotrophomonas maltophilia has at least two inducible beta-lactamases, L1 and L2, which can hydrolyze almost all classes of beta-lactam antimicrobial agents. This study was done to verify the indirect pathogenicity of S. maltophilia that could promote the growth of other beta-lactam agent-susceptible bacteria in a mixed culture. We counted CFU of beta-lactam agent-susceptible bacteria under the presence of imipenem or ceftazidime in a pure culture and mixed culture with S. maltophilia. Our results showed that beta-lactamase leaking from S. maltophilia can encourage the growth of Serratia marcescens and Pseudomonas aeruginosa even if imipenem or ceftazidime was supplemented. This study discovered a blind spot in chemotherapy against an indirect pathogen such as S. maltophilia.
嗜麦芽窄食单胞菌至少有两种诱导型β-内酰胺酶,即L1和L2,它们几乎能水解所有种类的β-内酰胺类抗菌药物。本研究旨在验证嗜麦芽窄食单胞菌在混合培养中促进其他对β-内酰胺类药物敏感细菌生长的间接致病性。我们分别在纯培养以及与嗜麦芽窄食单胞菌的混合培养中,计数了在亚胺培南或头孢他啶存在情况下对β-内酰胺类药物敏感细菌的菌落形成单位(CFU)。我们的结果表明,即使添加了亚胺培南或头孢他啶,嗜麦芽窄食单胞菌泄漏的β-内酰胺酶也能促进粘质沙雷氏菌和铜绿假单胞菌的生长。本研究发现了针对嗜麦芽窄食单胞菌这类间接病原体化疗中的一个盲点。